News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
599,167 Results
Type
Article (45699)
Company Profile (218)
Press Release (553250)
Section
Business (170851)
Career Advice (2478)
Deals (31466)
Drug Delivery (92)
Drug Development (75859)
Employer Resources (137)
FDA (16285)
Job Trends (13448)
News (302379)
Policy (30434)
Tag
Academia (2520)
Alliances (45534)
Alzheimer's disease (1218)
Approvals (16210)
Artificial intelligence (135)
Bankruptcy (331)
Best Places to Work (10825)
Biotechnology (164)
Breast cancer (131)
Cancer (1120)
Cardiovascular disease (99)
Career advice (2068)
Cell therapy (239)
Clinical research (60540)
Collaboration (396)
Compensation (135)
COVID-19 (2336)
C-suite (105)
Data (1143)
Diabetes (157)
Diagnostics (5613)
Drug pricing (88)
Earnings (62793)
Employer resources (123)
Events (80398)
Executive appointments (319)
FDA (16849)
Funding (374)
Gene therapy (191)
GLP-1 (599)
Government (3837)
Healthcare (17192)
Infectious disease (2420)
Inflammatory bowel disease (111)
Interviews (470)
IPO (14562)
Job creations (3035)
Job search strategy (1715)
Layoffs (349)
Legal (6652)
Lung cancer (165)
Manufacturing (178)
Medical device (11349)
Medtech (11353)
Mergers & acquisitions (16993)
Metabolic disorders (421)
Neuroscience (1508)
NextGen Class of 2024 (6040)
Non-profit (4275)
Northern California (1359)
Obesity (242)
Opinion (213)
Patents (107)
People (50382)
Phase I (18588)
Phase II (26559)
Phase III (20235)
Pipeline (467)
Postmarket research (2365)
Preclinical (7829)
Radiopharmaceuticals (243)
Rare diseases (231)
Real estate (4742)
Regulatory (21262)
Research institute (2277)
Resumes & cover letters (416)
Southern California (1202)
Startups (3635)
United States (12605)
Vaccines (541)
Weight loss (181)
Date
Today (103)
Last 7 days (348)
Last 30 days (3011)
Last 365 days (33156)
2024 (31101)
2023 (36885)
2022 (47490)
2021 (51336)
2020 (49833)
2019 (42853)
2018 (32495)
2017 (30048)
2016 (28582)
2015 (32925)
2014 (25552)
2013 (21678)
2012 (23015)
2011 (23671)
2010 (22067)
Location
Africa (813)
Arizona (118)
Asia (37120)
Australia (6112)
California (3070)
Canada (1241)
China (257)
Colorado (146)
Connecticut (146)
Europe (81550)
Florida (452)
Georgia (108)
Illinois (328)
Indiana (195)
Maryland (522)
Massachusetts (2414)
Michigan (147)
Minnesota (200)
New Jersey (936)
New York (927)
North Carolina (701)
Northern California (1359)
Ohio (134)
Pennsylvania (760)
South America (1076)
Southern California (1202)
Texas (461)
Utah (89)
Washington State (348)
599,167 Results for "medicines for malaria venture mmv".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Fosun Pharma’s Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
World Malaria Day is marked each year on April 25. World Health Organization gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world.
April 26, 2024
·
10 min read
Business
Novartis and MMV Move to Pivotal Study with New Class of Drug for Malaria
Novartis and Medicines for Malaria Venture are moving into Phase III for a combination treatment targeting the rise of artemisinin-resistant Malaria infection.
November 23, 2022
·
3 min read
·
Kate Goodwin
Hesperos Scientists Publish a New Study in Scientific Reports Titled: “Development of a Human Malaria-on-a-Chip Disease Model for Drug Efficacy and Off-Target Toxicity Evaluation”
A team of dedicated researchers at the human-on-a-chip company Hesperos, Inc. have taken on the challenge to investigate new ways to combat this disease in collaboration with the Medicines for Malaria Venture (MMV).
July 5, 2023
·
4 min read
Pharm Country
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
Ocean Biomedical (NASDAQ: OCEA ) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his malaria therapeutic antibody discoveries, targeted to both prevent malaria infection and treat severe malaria.
May 16, 2024
·
7 min read
Drug Development
Sail Biomedicines Receives Grants to Fight Malaria by Developing a New Class of RNA Medicines
Sail Biomedicines, Inc. announced that the Company has received two grants from the Bill & Melinda Gates Foundation to advance Sail’s first-in-category Endless RNA™ platform to develop secreted monoclonal antibodies and vaccines for malaria.
January 3, 2024
·
2 min read
Press Releases
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
November 21, 2024
·
4 min read
Press Releases
Novartis ranks first in 2024 Access to Medicine Index
November 20, 2024
·
6 min read
Press Releases
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms
August 27, 2024
·
8 min read
Press Releases
Chemify Receives Grant to Design and Discover New Drug Leads for Tuberculosis and Malaria Using Digital Chemistry Technology
October 1, 2024
·
2 min read
Press Releases
Versatope Receives Grants to Support Malaria Vaccine Development
July 29, 2024
·
2 min read
1 of 59,917
Next
